【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Burden of Disease
06.3 Etiology
06.4 Pathophysiology
06.4.1 Myocardial Dysfunction
06.4.2 MI
06.4.3 Electrical Dysfunction
06.5 Prognosis
06.6 Epidemiology
06.6.1 Prevalence of Coronary Artery Disease
06.7 Diagnosis
06.7.1 ECG
06.7.2 Blood Tests
06.7.3 Nuclear Scan
06.7.4 CT
06.8 Management
07.ACS Pipeline Landscape
07.1 Key Pipeline Molecules
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by ECG Output
10 Geographical Segmentation
11 Buying Criteria
12 Market Growth Drivers
13 Drivers and their Impact
14 Market Challenges
15 Impact of Drivers and Challenges
16 Market Trends
17 Trends and their Impact
18 Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 AstraZeneca
18.2.2 Bristol-Myers Squibb
18.2.3 Eli Lilly
18.2.4 GlaxoSmithKline
18.2.5 Sanofi
18.3 Other Prominent Vendors
19 Key Vendor Analysis
19.1 AstraZeneca
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2011-2013
19.1.5 Revenue by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.2 Bristol-Myers Squibb
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Product Offerings
19.2.4 Revenue by Geography
19.2.5 Business Strategy
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Eli Lilly
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue
19.3.4 Revenue by Geography
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 GlaxoSmithKline
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Revenue by Geography
19.4.6 Pipeline Products
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.5 Sanofi
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Business Segmentation
19.5.4 Revenue by Business Segmentation
19.5.5 Revenue Comparison 2012 and 2013
19.5.6 Revenue by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
20 Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Spectrum of ACS
Exhibit 3: Overview of ACS
Exhibit 4: Pathogenesis of ACS
Exhibit 5: Hospitalized Incident Cases of ACS 2014-2019 (millions)
Exhibit 6: Epidemiologic Transition of CV Diseases
Exhibit 7: Initial Drug Therapy for ACS
Exhibit 8: Adjunctive Drug Therapy for ACS
Exhibit 9: Surgery and Other Procedures
Exhibit 10: Snapshot of Global ACS Market 2014
Exhibit 11: Global ACS Market 2014-2019 (US$ billion)
Exhibit 12: Global ACS Market Share of Branded and Generic Drugs 2014 and 2019 (in Percent)
Exhibit 13: Segmentation of Global ACS Market by ECG Output
Exhibit 14: Diagrammatic Representation of STEMI, NSTEMI, and UA
Exhibit 15: Segmentation of Global ACS Market by ECG Output 2014
Exhibit 16: Global ACS Market by Geography 2014
Exhibit 17: Drivers of Global ACS Market
Exhibit 18: Comparison of Elderly Population 2012 and 2050 (Aged 65 and Older)
Exhibit 19: Challenges in Global ACS Market
Exhibit 20: Trends in Global ACS Market
Exhibit 21: Global Revenue of AstraZeneca for CV and Metabolic Diseases 2011-2013 (US$ million)
Exhibit 22: Estimated Filings of Brilinta/Brilique
Exhibit 23: Line Extensions for Brilinta/Brilique
Exhibit 24: Global Revenue of Brilinta/Brilique by AstraZeneca 2011-2013 (US$ million)
Exhibit 25: Global Revenue of Plavix by Bristol-Myers Squibb 2010-2012 (US$ million)
Exhibit 26: Revenue of Eli Lilly by Therapeutic Area 2013
Exhibit 27: Global Revenue of Effient by Eli Lilly 2010-2013 (US$ million)
Exhibit 28: Global Revenue of Arixtra by GlaxoSmithKline 2011-2013 (US$ million)
Exhibit 29: Global Revenue of Plavix by Sanofi 2011-2013 (US$ million)
Exhibit 30: Global Revenue of Lovenox by Sanofi 2011-2013 (US$ million)
Exhibit 31: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 32: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 33: AstraZeneca: Revenue by Geography 2013
Exhibit 34: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 35: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 36: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 37: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 38: Eli Lilly: Revenue by Geography 2013
Exhibit 39: GlaxoSmithKline: Business Segmentation 2013
Exhibit 40: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 41: GlaxoSmithKline: Revenue by Geography 2013
Exhibit 42: GlaxoSmithKline: Pipeline Products 2013
Exhibit 43: Sanofi: Business Segmentation
Exhibit 44: Sanofi: Revenue by Business Segmentation 2013
Exhibit 45: Sanofi: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 46: Sanofi: Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル:急性冠症候群(ACS)治療薬の世界市場2015-2019■ 英文:Global Acute Coronary Syndrome (ACS) Market 2015-2019
■ 発行日:2015年3月18日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5471
■ 調査対象地域:グローバル
- 世界主要国における軟性下疳検査市場2015The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 世界のクリーンルーム空間市場動向(2014-2018)About Cleanroom Space A cleanroom space helps reduce or eliminate contamination during the manufacturing of semiconductors and pharmaceutical and medical equipment by creating a special environment to ensure that environmental pollutants such as dust, airborne microbes, aerosol particles, and chemical vapors are present at a very low level or not at all. A cleanroom space can be described on the b …
- 世界のSeasonings, Dressings & Sauces市場におけるM&A動向(2014年2月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global seasonings, dressings & sauces market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global seasonings, dressings & sauces market throughout the month. Additionally, the …
- 医療産業向け分析・試験サービスの世界市場:安定性試験、原材料試験、方式検証、微生物試験、環境モニタリング、生物分析サービスThe global healthcare analytical testing services market is projected to reach USD 4.13 Billion by 2021 from USD 2.42 Billion in 2016, at a CAGR of 11.3% from 2016 to 2021. The market is expected to witness significant growth in the coming years due to the rising demand for analytical services for biologics and large-molecule drugs. Factors such as increasing outsourcing of analytical testing by p …
- 2014年戦略提言:Salmonella診断検査市場The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
- W&T Offshore, Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013W&T Offshore, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary W&T Offshore, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- モバイルロケーションコマース2012-2018(Mobile Location Commerce 2013 – 2018)Mobile commerce is expected to grow rapidly over the next five years. This growth is driven by the introduction of the tablets and the next generation smartphones. Mind Commerce predicts that the location commerce will be one of the key initiatives across the mobile/wireless value chain within the next three years. We believe that certain key areas, such as Mobile Social Commerce in the Cloud will …
- レベルセンサーの世界市場:タイプ別(接触、非接触)、用途別(連続レベルモニタリング、ポイントレベルモニタリング)、最終用途別(自動車、航空宇宙および防衛、エネルギーおよび電力、ヘルスケア、産業、その他)The global level sensor market is expected to generate revenue worth $4,446.90 million in 2019, and is projected to reach $7,368.10 million by 2026, to register a CAGR of 6.50% during the forecast period. Level sensor is a device that determines the level of fluids or other substances that flow in an open or closed system. There are two types of level measurements, namely, continuous and point lev …
- スマートビルディングの世界市場2015-2019About Smart Building A smart building connects BAS with the normal operations of a building such as HVAC, lighting, water supply, and fire emergency. It monitors and controls the energy usage of the building and helps in saving and improving the energy efficiency of the building. The concept of smart building has gained popularity worldwide as home developers have started to realize that these bui …
- 血管炎(Vasculitis):世界の治験レビュー(2015年上半期版)Vasculitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- クラウドコンピューティング市場分析:Analyzing Cloud ComputingCloud computing is a shift following the switchover from mainframe to client?server in the early 1980s. Cloud computing is web-based processing, whereby shared resources, software, and information are provided to computers and other devices on demand over the Internet. Cloud computing describes a new supplement, consumption, and delivery model for IT services based on the Internet, and it typicall …
- アフェレーシス装置の世界市場分析:用途別(腎疾患、血液学、神経学)、手順別(血栓塞栓症、LDL-アフェレーシス、血小板凝集症、白血球フェレーシス、光フェオレシス、赤血球凝集症)、セグメント予測、2013-2024The global apheresis equipment market is expected to reach USD 3.7 billion by 2024, according to a new report by Grand View Research, Inc. The apheresis equipment industry is expected to be impacted by factors such as rising demand for plasma, platelets and other blood components, increasing incidence of chronic illnesses, presence and development of ideal reimbursement policies across various reg …
- 急性心不全:治療薬のグローバル治験動向(2014年下半期)Acute Heart Failure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recru …
- 自動車ウインドシールドの世界市場予測(~2025年):合わせガラス、強化ガラスThe automotive industry is one of the key contributors to the overall GDP of the world and is growing significantly over the years. Growing economy and improving demographics have surged the demand for vehicles across the globe. As the demand for vehicles is growing, the demand for automotive components is also increasing significantly, especially in countries such as China and India. Also, new ve …
- Service Delivery Platforms The SOA-enabled Path to Integrate Legacy and IMS Networks (with Revenue Forecast 2010-2016)Service Delivery Platform (SDP) can be loosely defined as a standards based framework that facilitates the design, development, implementation and management of services required to run the operations of network services providers. The services could range from the basic voice connectivity to the state-of-the-art rich multimedia services. The most critical value-addition offered by the SDP methodo …